Evolent Health, Inc. (EVH) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1812 NORTH MOORE ST, SUITE 1705 ARLINGTON, VA 22209 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8741 - Management Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 150,995 | 246,547 | 104,203 | 96,583 | 101,250 | 165,147 | |||
| Cash and cash equivalent | 150,995 | 246,547 | 104,203 | 96,583 | 101,250 | 165,147 | |||
| Restricted cash and investments | 24,368 | 16,239 | 59,295 | 16,343 | 20,053 | 51,594 | |||
| Receivables | 357,401 | 429,161 | 413,346 | 406,786 | 372,361 | 426,561 | |||
| Other undisclosed current assets | 29,493 | 35,987 | 30,273 | 24,299 | 27,307 | 25,944 | |||
| Total current assets: | 562,257 | 727,934 | 607,117 | 544,011 | 520,971 | 669,246 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 5,342 | 5,726 | 6,134 | 9,244 | 9,905 | 10,790 | |||
| Property, plant and equipment | 77,273 | 74,440 | 73,151 | 73,941 | 75,297 | 76,044 | |||
| Long-term investments and receivables | 8,978 | 8,569 | 8,588 | 8,405 | 8,371 | 8,197 | |||
| Long-term investments | 8,978 | 8,569 | 8,588 | 8,405 | 8,371 | 8,197 | |||
| Intangible assets, net (including goodwill) | 1,788,490 | 1,805,201 | 1,817,476 | 1,834,121 | 1,827,828 | 1,847,884 | |||
| Goodwill | 1,137,321 | 1,137,320 | 1,137,320 | 1,137,342 | 1,116,538 | 1,116,539 | |||
| Intangible assets, net (excluding goodwill) | 651,169 | 667,881 | 680,156 | 696,779 | 711,290 | 731,345 | |||
| Capitalized contract cost, net | 12,504 | 13,334 | 13,378 | 13,203 | 13,419 | 12,471 | |||
| Restricted cash and investments | 2,607 | 15,059 | 14,998 | 14,925 | 16,646 | 16,737 | |||
| Other undisclosed noncurrent assets | 4,081 | 3,188 | 3,569 | 3,914 | 2,672 | 2,304 | |||
| Total noncurrent assets: | 1,899,275 | 1,925,517 | 1,937,294 | 1,957,753 | 1,954,138 | 1,974,427 | |||
| TOTAL ASSETS: | 2,461,532 | 2,653,451 | 2,544,411 | 2,501,764 | 2,475,109 | 2,643,673 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 133,346 | 157,344 | 162,386 | 170,541 | 123,818 | 242,445 | |||
| Accounts payable | 69,460 | 57,813 | 96,025 | 50,087 | 39,030 | 77,346 | |||
| Accrued liabilities | 63,886 | 99,531 | 66,361 | 120,454 | 84,788 | 165,099 | |||
| Deferred revenue | 2,333 | 5,017 | 2,507 | 2,621 | 4,558 | 6,136 | |||
| Debt | 172,119 | 171,793 | 171,467 | ||||||
| Other undisclosed current liabilities | 249,721 | 404,943 | 379,141 | 350,521 | 354,998 | 410,441 | |||
| Total current liabilities: | 557,519 | 739,097 | 715,501 | 523,683 | 483,374 | 659,022 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 648,455 | 647,532 | 490,520 | 599,668 | 598,784 | 597,901 | |||
| Long-term debt, excluding current maturities | 648,455 | 647,532 | 490,520 | 599,668 | 598,784 | 597,901 | |||
| Liabilities, other than long-term debt | 22,978 | 29,968 | 38,853 | 44,750 | 47,365 | 50,294 | |||
| Deferred revenue | 330 | 293 | 586 | 879 | |||||
| Deferred income tax liabilities | 10,450 | 11,114 | 10,900 | 11,892 | 12,559 | 13,378 | |||
| Other liabilities | 3,787 | 3,269 | 2,984 | 3,247 | 3,431 | 3,568 | |||
| Operating lease, liability | 8,411 | 15,585 | 24,969 | 29,318 | 30,789 | 32,469 | |||
| Other undisclosed noncurrent liabilities | 107,775 | 108,105 | 108,105 | 107,812 | 107,519 | 107,226 | |||
| Total noncurrent liabilities: | 779,208 | 785,605 | 637,478 | 752,230 | 753,668 | 755,421 | |||
| Total liabilities: | 1,336,727 | 1,524,702 | 1,352,979 | 1,275,913 | 1,237,042 | 1,414,443 | |||
| Temporary equity, including noncontrolling interest | 228,800 | 193,228 | 190,173 | 187,166 | 184,206 | 181,294 | |||
| Equity | |||||||||
| Equity, attributable to parent | 896,005 | 935,521 | 1,001,259 | 1,038,685 | 1,053,861 | 1,047,936 | |||
| Common stock | 1,175 | 1,174 | 1,166 | 1,166 | 1,163 | 1,162 | |||
| Treasury stock, value | (21,123) | (21,123) | (21,123) | (21,123) | (21,123) | (21,123) | |||
| Additional paid in capital | 1,782,992 | 1,802,634 | 1,803,786 | 1,818,024 | 1,810,054 | 1,805,679 | |||
| Accumulated other comprehensive loss | (1,707) | (1,729) | (1,753) | (1,367) | (1,355) | (1,308) | |||
| Accumulated deficit | (865,332) | (845,435) | (780,817) | (758,015) | (734,878) | (736,474) | |||
| Total equity: | 896,005 | 935,521 | 1,001,259 | 1,038,685 | 1,053,861 | 1,047,936 | |||
| TOTAL LIABILITIES AND EQUITY: | 2,461,532 | 2,653,451 | 2,544,411 | 2,501,764 | 2,475,109 | 2,643,673 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 444,328 | 483,649 | 646,542 | 621,401 | 647,145 | 639,653 | ||
| Cost of revenue | (343,943) | (381,178) | (570,831) | (540,708) | (540,302) | (535,547) | ||
| Gross profit: | 100,385 | 102,471 | 75,711 | 80,693 | 106,843 | 104,106 | ||
| Operating expenses | (98,350) | (104,373) | (98,507) | (96,761) | (99,055) | (108,607) | ||
| Other undisclosed operating income (loss) | (3,206) | 280 | 4,200 | (200) | (8,908) | |||
| Operating income (loss): | (1,171) | (1,622) | (18,596) | (16,268) | 7,788 | (13,409) | ||
| Nonoperating income | 1,049 | 1,226 | 1,211 | 751 | 1,265 | 2,558 | ||
| Investment income, nonoperating | 1,084 | 1,274 | 830 | 794 | 1,370 | 2,550 | ||
| Other nonoperating income (expense) | (35) | (48) | 381 | (43) | (105) | 8 | ||
| Interest and debt expense | (11,601) | (10,385) | (6,720) | (6,010) | (5,995) | (5,997) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (11,723) | (10,781) | (24,105) | (21,527) | 3,058 | (16,848) | ||
| Income (loss) from equity method investments | 197 | (19) | 182 | (2,229) | (1,700) | 306 | ||
| Other undisclosed loss from continuing operations before income taxes | (9,196) | (52,348) | (173) | |||||
| Income (loss) from continuing operations before income taxes: | (20,722) | (63,148) | (23,923) | (23,756) | 1,358 | (16,715) | ||
| Income tax expense (benefit) | 825 | (1,470) | 1,121 | 619 | 238 | (565) | ||
| Income (loss) from continuing operations: | (19,897) | (64,618) | (22,802) | (23,137) | 1,596 | (17,280) | ||
| Other undisclosed net loss | (31,193) | |||||||
| Net income (loss): | (51,090) | (64,618) | (22,802) | (23,137) | 1,596 | (17,280) | ||
| Other undisclosed net income attributable to parent | 31,193 | |||||||
| Net income (loss) attributable to parent: | (19,897) | (64,618) | (22,802) | (23,137) | 1,596 | (17,280) | ||
| Preferred stock dividends and other adjustments | (31,193) | (7,632) | (7,813) | (8,094) | (7,979) | (7,945) | ||
| Net loss available to common stockholders, diluted: | (51,090) | (72,250) | (30,615) | (31,231) | (6,383) | (25,225) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2025 Q3 | 6/30/2025 Q2 | 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (51,090) | (64,618) | (22,802) | (23,137) | 1,596 | (17,280) | ||
| Comprehensive income (loss): | (51,090) | (64,618) | (22,802) | (23,137) | 1,596 | (17,280) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 22 | (7,608) | (8,199) | (8,106) | (8,026) | (7,996) | ||
| Comprehensive loss, net of tax, attributable to parent: | (51,068) | (72,226) | (31,001) | (31,243) | (6,430) | (25,276) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.